Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher. Levi Downs, Jr., M.D., principal investigator for the multicenter, randomized Phase II clinical trial, has … Continue reading Thalidomide Shows Promise For Treatment Of Recurrent Ovarian Cancer